Category: Hormones & Pharmacological Agents
-
Polycystic Ovary Syndrome Tied To Cognitive Problems
Those with polycystic ovary syndrome may be more likely to experience memory and thinking problems in middle age according to recent research published in Neurology. However, the study is not able to prove polycystic ovary syndrome causes cognitive issues, it is only able to show an association.u00a0
-
Third Major Study Shows Multivitamins May Improve Memory And Slow Cognitive Decline
Approximately 1 in 4 Americans will be in the age bracket for elevated risks of cognitive decline and Alzheimeru2019s disease by 2060 unless interventions can help preserve cognitive functions before the deficits begin to occur. Two previous published studies of the large-scale, nationwide, randomized COcoa Supplement and Multivitamin Outcomes Study (COSMOS) trial suggested a positive…
-
The Green Mediterranean Diet May Be Twice As Healthy As Mediterranean Diet
A randomized controlled clinical trial led by Prof. Iris Shai of Ben-Gurion University of the Negev, Israel, an adjunct Professor from the Harvard School of Public Health and an honorary professor at the University of Leipzig, Germany published in the Journal of the American College of Cardiology suggests that the green Mediterranean diet which is…
-
Menopause Belly: Battling The Bulge
Fighting belly fat is not exactly easy for anyone, but menopause can take it to another level with challenging hormonal changes occurring that can lead to extra weight around the middle, but there are ways to battle the u201cmenopotu201d unwanted weight gain.u00a0 A lot of people feel as if weight gain is rather inevitable once…
-
Nuts May Help To Reduce Metabolic Syndrome
Consuming tree nuts every day may help to reduce the risk of metabolic syndrome by improving waist circumference, lipid biomarkers, and/or insulin levels without calorie restriction among young adults, according to a study recently published in the journal Nutrients.u00a0
-
‘Exceptional’ results in phase III leukemia trial
Personalised treatment for the most common form of adult leukaemia helps patients survive for longer and stay in remission, a phase III trial has found. The trial, by the University of Leeds, has been identified as groundbreaking research by the New England Journal of Medicine and the 65th American Society of Hematology (ASH) Annual Meeting…
-
Tirzepatide enhances weight loss with sustained treatment but discontinuation leads to weight regain
The current class of anti-obesity drugs is proving remarkably effective at removing excess pounds. However, a phase 3 randomized clinical trial led by researchers at Weill Cornell Medicine and New York-Presbyterian found that people who stopped taking the medication regained much of that weight within a year. At the same time, the study shows that…
-
Major breakthrough for severe asthma treatment
A landmark study has shown that severe asthma can be controlled using biologic therapies, without the addition of regular high-dose inhaled steroids which can have significant side effects. The findings from the multinational SHAMAL study, published in The Lancet, demonstrated that 92% of patients using the biologic therapy benralizumab could safely reduce inhaled steroid dose…
-
Semaglutide (Wegovy) in Overweight Non-Diabetic Heart Patients Slashes the Risk of Death!
Article courtesy of Dr. Joel Kahn, MD, who is a Clinical Professor of Medicine at Wayne State University School of Medicine, one of the world’s top cardiologists, a best-selling author, lecturer, and a leading expert in plant-based nutrition and holistic care.
-
Do the 2 Top Statin Medications Have Different Diabetes Risks?
Article courtesy of Dr. Joel Kahn, MD, who is a Clinical Professor of Medicine at Wayne State University School of Medicine, one of the world’s top cardiologists, a best-selling author, lecturer, and a leading expert in plant-based nutrition and holistic care.